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2. Abstract  
Title: Spermatogenesis in Tumor-bearing Testes in Germ Cell Testicular Cancer Patients 
Abstract 
Study question: What are the factors that might indicate a greater likelihood of success in 
oncologic testicular sperm extraction (Onco-TESE)? 
Summary answer: Smaller tumor diameter and wide noncancerous testicular tissue width 
(NCTW) are positive predictors of spermatogenesis in testicular germ cell tumors (TGCTs) 
patients.  
What is known already: Onco-TESE is a key modality for fertility preservation in cases of 
inadequate pretreatment sperm collection and azoospermic men with testicular cancer. TGCTs 
are known to reduce sperm quality such that approximately 10% of these patients are 
azoospermic, making surgical testicular sperm extraction at the same time of orchiectomy 
their only means of fertility preservation. 
Study design, size, duration: This study is a retrospective analysis performed in a single 
university hospital from 2002 to 2014. 
Participants/materials, setting, methods: Participants were 102 male patients (104 testes) 
who underwent inguinal orchiectomy and were diagnosed with a germinoma at the Dokkyo 
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Medical University Koshigaya Hospital. In each specimen, the Johnsen Score Count (JSC) in 
seminiferous tubules at each established distance from the tumor margin (1 mm, 2.5 mm, 5 
mm, 7.5 mm, 10 mm, and 12.5 mm) was determined. We analyzed relationships between age, 
tumor histopathologic type, tumor size (maximum diameter), distance from the tumor, 
non-tumor tissue width, and JSC. 
Main results and the role of chance: The 104 specimens consisted of 78 seminomas and 26 
non-seminomatous TGCTs. The average JSC was 4.7±2.4 in seminomas and 3.9±2.5 in 
non-seminomatous germ cell tumors, with no significant difference between the two subtypes. 
Multiple linear regression analysis showed that tumor size had a negative influence on 
spermatogenesis. The greater the distance of the seminiferous tubules from the tumor, the 
better the preservation of spermatogenesis. Mature spermatozoa were identified in 93.0% of 
specimens with NCTW ≥7.5 mm and in 41.3% of those with NCTW <7.5 mm. 
Limitations, reasons for caution: Study data were obtained retrospectively, which might 
have affected the quality of data. 
Wider implications of the findings: When Onco-TESE is conducted at distant sites from 
tumors, the rate of sperm extraction is high and contamination of tumor cells can be prevented. 
By measuring non-testicular cancerous margin before the operation, the possibility of sperm 
4 
 
extraction can be predicted and biopsy of the contralateral testis can be considered based on 
the results.  
Study funding/competing interest(s): none 
Trial registration number: none 
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4. Introduction 
Generally, testicular germ cell tumors (TGCTs) occur more frequently in patients of 
reproductive age. Therefore, their influence on spermatogenesis is an important considerati 
TGCTs have a comparatively high survival rate and radical cure is possible, but postoperative 
chemotherapy and radiotherapy significantly reduces fertility, sometimes permanently 
(Meseguer et al., 2003; Dohr, 2010). Previous reports indicate that it is difficult to predict 
whether spermatogenesis will recover to the preoperative level after chemotherapy and 
radiotherapy (Gandini et al., 2006). Additionally, in a study involving 1158 patients with 
TGCTs, Rives et al reported that the ideal time to perform sperm retrieval in patients with 
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TGCTs was preoperatively, because the sperm concentration was the most favorable before 
inguinal orchiectomy (Rives et al., 2012). Based on this, preoperative examination of the 
semen is crucial and preoperative semen cryopreservation is highly recommended. However, 
previous studies report that azoospermia has been observed in 10–15% of patients with 
TGCTs during preoperative semen analysis and 50% or more patients have oligozoospermia 
(Williams et al., 2009; Fraietta et al., 2010). It is possible to cryopreserve sperm from 
patients with oligozoospermia but not azoospermia, which is instead an indication for 
onco-testicular sperm extraction (onco-TESE). This technique involves collection of semen 
from excised testes following orchiectomy. There have been cases of pregnancy reported 
following intracytoplasmic sperm injection with sperm collected using onco-TESE 
(Descombe et al., 2008). Against this background, semen tests should always be conducted 
preoperatively in patients with TGCTs, and if azoospermia is noted, onco-TESE should be 
proactively recommended. 
However, it will not necessarily be possible to collect semen from all patients using 
onco-TESE (Schrader et al., 2003). There have been few studies investigating the factors 
that influence spermatogenesis in patients with TGCTs. If we can elucidate the factors that 
influence the difficulty of sperm collection during onco-TESE, the findings will be useful for 
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establishing a strategy to allow patients with TGCTs to maintain fertility. Reports that have 
studied the relationship between spermatogenesis in the affected side in patients with TGCTs 
and three factors—tumor size, tumor markers, and tumor tissue type—have reported that the 
only relevant factor was tumor size (Choy et al., 2013). 
Previously, we used pathological specimens taken from patients diagnosed with TGCTs who 
underwent inguinal orchiectomy to investigate the relationship between age at the time of 
surgery, tumor tissue type, maximum tumor diameter, and spermatogenesis. In addition, 
reports have stated that spermatogenesis worsens with increasing proximity to the tumor in 
the residual normal testicular tissue (Ho et al., 1992), but no reports have investigated the 
relationship between the actual distance from the tumor and spermatogenesis. 
In this study, we investigated spermatogenesis and distance from the tumor margin to study 
whether it is possible to predict which sites offer the highest chances of sperm retrieval on the 
affected side when performing onco-TESE. 
 
5. Materials and Methods 
Participants 
Participants were 102 male patients (104 testes) diagnosed with a TGCT, who underwent 
inguinal orchiectomy and were diagnosed with a germinoma at Dokkyo Medical University 
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Koshigaya Hospital between April 2002 and April 2014. The study protocol was approved by 
the institutional review board and complied with all institutional guidelines of Dokkyo 
Medical University Koshigaya Hospital. 
Creation of histopathology specimens and evaluation of spermatogenesis 
After fixing the excised testes in 10% buffered formalin, they were sliced so as to include the 
longest cut surface of the tumor and paraffin-embedded specimens were created. These were 
used to create 5-μm sections from which histopathology specimens were created after 
hematoxylin and eosin staining. 
TGCT tissue was classified according to the Union for International Cancer Control (UICC) 
guidelines. Tumor size was measured using a pair of vernier calipers along the major axis of 
the tumor. In the case of multiple tumors, the major axis of the largest tumor was used as the 
representative value. 
The Johnsen Score Count (JSC) (Johnsen et al., 1970) was used to evaluate 
spermatogenesis. Two individuals (KS, HY) were responsible for the evaluation of 
spermatogenesis and both were blinded to patient backgrounds. Spermatogenesis was 
evaluated in 20 testes during the preliminary experiment and the concordance rate was 90% 
(data not shown). If evaluations were not in concordance, a third individual (HO) was 
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included, discussions were conducted, and a decision was made in the final evaluation. 
The distance from the tumor margin to the seminiferous tubules was measured by a 
micrometer. The mean JSC value was calculated using 25 or more seminiferous tubules 
observed in the cross section at each established distance from the tumor margin (1 mm, 2.5 
mm, 5 mm, 7.5 mm, 10 mm, and 12.5 mm) to evaluate spermatogenesis at each location. The 
JSC score was considered 0 in the event the testis was completely replaced by tumor tissue 
with no residual normal testicular tissue. 
We used the median JSC value at each distance from the tumor margin, as described above, as 
the representative value for spermatogenesis in each patient. The noncancerous testicular 
tissue width (NCTW) was defined as the distance between the tumor margin and the tunica 
albuginea, measured by a micrometer. 
Statistics 
The relationship between spermatogenesis and patient age, maximum tumor diameter, and 
distance from the tumor margin was investigated using multiple regression analysis. 
Spermatogenesis on the affected side was compared using the Mann-Whitney test between 
patients in the following groups: age <35 years vs. ≥35 years, seminoma vs. 
non-seminomatous tumors, and NCTW <7.5 mm vs. NCTW ≥7.5 mm.  
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The presence of spermatogenesis on the affected side in patients aged <35 years was 
compared with that in patients aged ≥35 years using the chi-square test. The relationship 
between spermatogenesis and patient age, maximum tumor diameter, and tissue type was 
investigated using multiple regression analysis. SPSS version 18.0 (IBM, Armonk, NY) was 
used for statistical analysis. A p value of <0.05 was considered statistically significant. 
 
6. Results 
Patient backgrounds of the 102 individuals (104 testes) are shown in Table 1. Table 2 shows 
whether the patients desired a baby at the time of diagnosis and whether they had already 
fathered a child. We obtained the pre-operative semen values in 7 patients only (Table 3). Of 
these 7 patients, spermatozoa were cryopreserved in 5 for fertility preservation. Tissue type 
breakdown revealed 78 cases of seminoma and 26 cases of non-seminomatous tumors (19 
mixed germ cell tumors, 4 embryonal carcinoma, 1 choriocarcinoma, 1 yolk sac tumor, and 1 
teratocarcinoma). In 21 cases, no seminiferous tubules and only tumor was found in the 
specimen. We excluded these 21 cases for analysis. Single regression analysis showed that 
maximum tumor diameter but not age was significantly negatively correlated with 
spermatogenesis (age: regression coefficient [RC] = −0.017, p = 0.37, Fig. 1; maximum 
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diameter: RC = −0.422, p<0.001, Fig. 2). 
Spermatogenesis in the testes on the affected side in patients aged <35 years was evaluated as 
a JSC score of 4.9 ± 2.0 (mean ± SD), which was significantly higher than the JSC score of 
3.5 ± 2.6 (p=0.031) for those aged ≥35 years. Spermatozoa were more frequently observed in 
patients aged <35 years (74%) than in those aged ≥35 years (44%; p=0.024). Table 4 shows 
the detailed data of the two groups separated by age. We found no significant difference in 
spermatogenesis between seminoma (4.7 ± 2.4) and non-seminomatous tumors (3.9 ± 2.5) 
(Figure 3). Multiple regression analysis showed that tumor diameter had a negative influence 
on spermatogenesis, but age and tissue type had no significant influence. 
In terms of the distance from the tumor margin and spermatogenesis, spermatogenesis was 
maintained to a greater degree in the seminiferous tubules that were more distant from the 
tumor (Fig. 4). Spermatozoa were observed in 93% (n = 30) of patients when NCTW was 7.5 
mm or greater, but was seen in only 41% (n = 74) of patients when NCTW was less than 7.5 
mm (p<0.001). 
 
7. Discussion 
Due to advances in multidisciplinary healthcare, TGCTs have become curable, and 
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maintaining fertility presents a challenge for cancer survivors (Ginsberg, 2011). If 
spermatozoa are observed in the semen preoperatively, it should ideally be cryopreserved for 
preservation of fertility (Loren et al., 2013). However, if preoperative azoospermia 
precludes sperm retrieval, then onco-TESE (Descombe et al., 2008; Schrader et al., 
2003), which is collection of sperm from the excised testes at the time of surgery, should be 
performed. At this time, knowing which sites to search preferentially in the testes is important 
for ensuring a maximum sperm retrieval rate. 
For this reason, we investigated spermatogenesis-influencing factors on the affected side in 
102 TGCT patients. First, we examined spermatogenesis using three parameters; namely, 
patient age, tumor tissue type, and maximum tumor diameter, and then investigated the 
relationship between spermatogenesis and distance from the tumor margin, NCTW, and the 
presence of spermatogenesis. 
The results of this study show no correlation between tumor tissue type (seminoma/ 
non-seminomatous tumors) and spermatogenesis. The results of a study by Rives et al 
involving 1158 TGCT patients indicated that sperm concentration was lower in patients with 
seminomas than in patients with non-seminomatous tumors (Rives et al., 2012), but no 
statistically significant difference due to tissue type was observed in our study. 
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The negative effect of female age on fertility is well known. Meanwhile, the effect of male 
age on fertility has been controversial. Okada and his colleagues previously reported that in 
azoospermic patients with nonmosaic Klinefelter’s syndrome, the percentage of successful 
recovery of spermatozoa decreased after the age of 35 years (Okada H, et al., 2005). This fact 
suggested the negative effect of male age on fertility. In this study, we separated the patients 
based on the cut off age of 35 years, the age when a woman’s fertility starts to decrease 
(Maheshwari A, et al., 2008). Spermatogenesis was significantly higher and spermatozoa 
were observed significantly more frequently in patients aged <35 years, compared with those 
≥35 years.  
Choy et al reported that maximum tumor diameter had a significantly negative influence on 
spermatogenesis in their study of 77 patients (Choy et al., 2013) and Delouya et al reported 
a moderately negative correlation between tumor volume and spermatogenesis in their study 
of 77 patients (Delouya et al., 2010). Similar to these past studies, multiple linear 
regression analysis in our study indicated that maximum tumor diameter had a significantly 
negative influence on spermatogenesis. 
When we investigated the distance from the tumor margins and spermatogenesis, we found 
that spermatogenesis increased with distance from the tumor margins. In addition, 
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spermatozoa were observed in 93% of patients when NCTW was ≥7.5 mm or greater, but 
sperm was observed significantly less (41%) when patients’ NCTW was <7.5 mm. Based on 
these findings, spermatogenesis on the affected side in patients with TGCTs is more likely to 
be maintained in the seminiferous tubules that are farther from the tumor and spermatozoa are 
more likely to be present when the NCTW is greater. Ho et al also reported that 
spermatogenesis worsened in the seminiferous tubules surrounding the tumor in an 
investigation of 28 TGCT patients [10]. NCTW is highly dependent on size, location and 
shape of the tumor. Unfortunately, we could not analyze the location and shape of the tumor 
in this retrospective study. Table 5 shows the information about tumor diameter and 
proportion relative to the whole testis in patients with NCTW<7.5 mm and in those with 
NCTW≥7.5 mm. Imaging evaluation of the residual testicular tissue using ultrasound of the 
testes or MRI may become an effective preoperative step for predicting the results of sperm 
retrieval during onco-TESE.  
 To date, Hadded et al have mentioned tumor toxicity, high temperature, mass effect, and 
paracrine effect (interleukin-1, interferon-γ, leukemia-inhibiting factor) as factors affecting 
testicular tissue with residual tumor (Haddad et al., 2014). In our study, there was no 
additional investigation of these factors, but we have begun experimentation in animal models 
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to elucidate the mechanism of this spermatogenic dysfunction. 
Surgically recovering spermatozoa from the contralateral testis is an alternative method for 
fertility preservation in unilateral testicular cancer patients. Some of the recovered 
spermatozoa from the ipsilateral testis may have been affected by the biochemical malignant 
environment, or they may come from seminiferous tubules with in situ carcinoma. Biopsy of 
the contralateral testis and recovering spermatozoa could overcome these problems, and could 
exclude the presence of a simultaneous carcinoma in situ. Sofikitis and his colleagues 
indicated that autotransplantation of frozen/thawed germ cells isolated from the contralateral 
healthy testis as a promising method of fertility preservation (Sofikitis et al., 2003). In this 
procedure, frozen-thawed germ cells from the neoplastic testis can be transplanted back to the 
rete testis of the contralateral testis after chemotherapy. Semen samples should be evaluated 
for the presence of spermatozoa several months after transplantation. They suggested that 
autotransplantation of testicular frozen-thawed germ cells after chemotherapy may represent a 
means of colonizing the human testis with its own cells, with the overall target of appearance 
of spermatozoa in the ejaculate. However, we should bear in mind that biopsy of the 
contralateral testis has the potential risk of postoperative hypogonadism, and it cannot be 
performed in patients with a single testis.  
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Limitations of our study include unknown preoperative semen findings in several cases. We 
were unable to compare spermatogenesis determined using preoperative semen findings with 
that determined histopathologically. Furthermore, the evaluation of spermatogenesis involved 
the use of histopathology specimens that included the largest cut surface of the tumor, so it 
was not possible to evaluate spermatogenesis in the total volume of noncancerous testicular 
tissue. When onco-TESE is performed, all of the excised non-cancerous testicular tissue is 
examined in detail using a surgical microscope and sperm collection is attempted, so it is 
possible that the presence of spermatogenesis detected in the present study was less than it 
would have been during onco-TESE in practice. Another limitation of this study is that 
patients with probably normal spermatogenesis were included in this study. When patients 
have sperm in their ejaculate, sperm cryopreservation would be performed for fertility 
preservation. Onco-TESE would not be offered for those patients. Only azoospermic or 
severely oligoasthenoteratozoospermic patients are candidates for onco-TESE. Therefore, a 
study that limits subjects to those whose seminograms are azoospermic or severely 
oligoasthenoteratozoospermic would be more preferable for the analysis. Going forward, we 
believe a prospective study is required to compare the results of sperm retrieval with the 
results of spermatogenesis determined using histopathology specimens.  
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14. Table 
15. Figure legends  
Figure 1. 
Influence of age on spermatogenesis assessed by Johnsen score count (JSC). Simple linear 
regression was performed. Age was not associated with spermatogenesis in tumor-bearing 
testes (p=0.37, regression coefficient [RC]= −0.017). 
Figure 2. 
Influence of tumor size on spermatogenesis assessed by JSC. Simple linear regression was 
performed. Tumor size was negatively associated with spermatogenesis in the tumor-bearing 
testes (p<0.001, RC= −0.422). 
Figure 3. 
Average JSC in seminomas and nonseminomatous and mixed germ cell tumors. No 
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significant difference was found between the two subtypes. 
Figure 4. 
The average JSC in the seminiferous tubules at 1 mm, 2.5 mm, 5 mm, 7.5 mm, 10 mm, and 
12.5 mm distance from tumor margin. The farther the seminiferous tubules were located, the 
better the preservation of spermatogenesis.  
